Epilepsy Monitoring Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Epilepsy Monitoring Devices Market By Product (Wearable Devices, Conventional Devices, and Implantable Devices), Technology (Vagus Nerve Stimulation (VNS), Responsive Neurostimulation, Deep Brain Stimulation, and Accelerometry), End User (Hospitals and Clinics, Ambulatory Surgery Centers, Neurology Centers, Diagnostic Centers, and Home Care Settings) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Epilepsy Monitoring Devices Market size is valued at USD 525 million in 2021 and is poised to grow at a significant CAGR of 4.9% over 2022–2028. Epilepsy is a neurological disorder, it affects the central nervous system in which brain activity becomes abnormal, causing seizures or periods of unusual behaviour, sensations, temporary confusion, uncontrollable jerking movements of arms and legs, and loss of awareness. Anyone can develop epilepsy irrespective of males and females of all races, ethnic backgrounds, and ages. According to WHO, around 50 million people worldwide have epilepsy, and nearly 80% of people with epilepsy live in low- and middle-income countries. It is estimated that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. The increasing prevalence of epilepsy and incidence of head injuries, brain cancer, and infections are driving the epilepsy monitoring devices market share. Around 5 million people are diagnosed with epilepsy each year worldwide. Moreover, the rise in research & development activities with the immense investment and the awareness about epilepsy monitoring devices is expected to increase the epilepsy devices market demand. Various awareness programs organized by organizations and government initiatives will further increase the awareness and growth of the market.  However, the high cost of complex epilepsy monitoring procedures and devices is a significant restrain that limits the market growth. For instance, handling MEG devices is very challenging for healthcare facilities in countries that have implemented this monitoring equipment. Although increasing demand for non-invasive and minimally invasive devices shows the opportunity in the global epilepsy monitoring devices market trends. Invasive monitoring is a very risky, intricate, and painful process that needs direct intervention with the brain’s sensitive tissues. As a result, patients and doctors are more interested in using minimally or non-invasive epilepsy monitoring technologies.

 

Recent Market Developments:

In Feb 2022, Angelini Pharma, an international Italian pharmaceutical company, announced that it would provide patients and healthcare professionals with innovative solutions to improve the care of patients with epilepsy.

In January 2021, Nihon Kohden launched disposable EEG electrodes to help prevent cross-contamination between patients and healthcare workers.

Epilepsy Monitoring Devices Market

MARKET SUMMARY
-
4.9%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 4.9%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North America

Epilepsy Monitoring Devices Market

  • The global epilepsy monitoring devices market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global epilepsy monitoring devices market gives historical, current, and future market sizes on the basis of product, technology, end-user, and geography.
Key Players
  • Botanix pharmaceuticals
  • Sun Pharmaceutical industry
  • Alembic Pharmaceuticals
  • Bausch Health Companies
  • Teva Pharmaceutical Industries Ltd.
Epilepsy Monitoring Devices Market Dynamics

Increasing incidence and prevalence of epilepsy are driving the growth of the global epilepsy monitoring devices market due to the increasing brain injuries, increased risk of neurocysticercosis, the higher incidence of road traffic injuries and birth-related injuries, variations in medical infrastructure, and the availability of preventive health programs and accessible care. According to CDC, about 0.6% of children aged 0-17 years have active epilepsy.


North-America Got Significant Share

Epilepsy Monitoring Devices Market

The global epilepsy market is segmented into America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The epilepsy monitoring devices market in the Asia Pacific is likely to hold a significant revenue share in 2021, and, in the following years, it is predicted to increase rapidly. The United States is the industry's center with the major epilepsy monitoring devices market worldwide. With developed healthcare infrastructure, favorable government policies and initiatives, and the presence of headquarters of major key companies in the region such as Boston Scientific Corporation, Natus Medical, Abbott Laboratories, and Empatica are key drivers of the market in the region. However, rising epilepsy cases in North America are also increasing the market potential. The European epilepsy devices market is expected to grow during the upcoming years due to reimbursement availability, the growing geriatric population, government initiatives and awareness programs, and technological advancements in therapeutic devices.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The epilepsy monitoring devices market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Epilepsy Monitoring Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The epilepsy monitoring devices market is projected to expand at a CAGR of 4.9% during the forecast period

Koninklijke Philips N.V, Natus Medical, Inc. (US), Compumedics Limited (Australia), Empatica, Inc. (US), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan)

North America is the fastest-growing region for epilepsy monitoring devices market


Report

Table Of Content

1. Executive Summary
2. Global Epilepsy Monitoring Devices Market Introduction
2.1. Global Epilepsy Monitoring Devices Market – Taxonomy
2.2. Global Epilepsy Monitoring Devices Market –Definitions
2.2.1. By Product
2.2.2. By Technology
2.2.3. By End User
2.2.4. By Region
3. Global Epilepsy Monitoring Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Epilepsy Monitoring Devices Market Dynamic Factors – Impact Analysis
3.6. Global Epilepsy Monitoring Devices Market – Competition Landscape
3.7. Epidemiology
4. Global Epilepsy Monitoring Devices Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Epilepsy Monitoring Devices Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Wearable Devices
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Conventional Devices
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Implantable Devices
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Epilepsy Monitoring Devices Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Vagus Nerve Stimulation (VNS)
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Responsive Neurostimulation
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Deep Brain Stimulation
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Accelerometry
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Epilepsy Monitoring Devices Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Hospitals and Clinics
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Ambulatory Surgery Centers
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Neurology Centers
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Diagnostic Centers
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Home Care Settings
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Epilepsy Monitoring Devices Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Epilepsy Monitoring Devices Market – Opportunity Analysis Index, By Product, By Technology, By End User, and Region, 2022-2028
9. North America Epilepsy Monitoring Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Wearable Devices
9.1.2. Conventional Devices
9.1.3. Implantable Devices
9.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Vagus Nerve Stimulation (VNS)
9.2.2. Responsive Neurostimulation
9.2.3. Deep Brain Stimulation
9.2.4. Accelerometry
9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Hospitals and Clinics
9.3.2. Ambulatory Surgery Centers
9.3.3. Neurology Centers
9.3.4. Diagnostic Centers
9.3.5. Home Care Settings
9.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Epilepsy Monitoring Devices Market – Opportunity Analysis Index, By Product, By Technology, By End User, and Country, 2022-2028
9.6. North America Epilepsy Monitoring Devices Market Dynamics – Trends
10. Europe Epilepsy Monitoring Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Wearable Devices
10.1.2. Conventional Devices
10.1.3. Implantable Devices
10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Vagus Nerve Stimulation (VNS)
10.2.2. Responsive Neurostimulation
10.2.3. Deep Brain Stimulation
10.2.4. Accelerometry
10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Hospitals and Clinics
10.3.2. Ambulatory Surgery Centers
10.3.3. Neurology Centers
10.3.4. Diagnostic Centers
10.3.5. Home Care Settings
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Epilepsy Monitoring Devices Market – Opportunity Analysis Index, By Product, By Technology, By End User, and Country, 2022-2028
10.6. Europe Epilepsy Monitoring Devices Market Dynamics – Trends
11. Asia-Pacific Epilepsy Monitoring Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Wearable Devices
11.1.2. Conventional Devices
11.1.3. Implantable Devices
11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Vagus Nerve Stimulation (VNS)
11.2.2. Responsive Neurostimulation
11.2.3. Deep Brain Stimulation
11.2.4. Accelerometry
11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Hospitals and Clinics
11.3.2. Ambulatory Surgery Centers
11.3.3. Neurology Centers
11.3.4. Diagnostic Centers
11.3.5. Home Care Settings
11.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Epilepsy Monitoring Devices Market – Opportunity Analysis Index, By Product, By Technology, By End User, and Country, 2022-2028
11.6. Asia-Pacific Epilepsy Monitoring Devices Market Dynamics – Trends
12. Latin America Epilepsy Monitoring Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Wearable Devices
12.1.2. Conventional Devices
12.1.3. Implantable Devices
12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Vagus Nerve Stimulation (VNS)
12.2.2. Responsive Neurostimulation
12.2.3. Deep Brain Stimulation
12.2.4. Accelerometry
12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Hospitals and Clinics
12.3.2. Ambulatory Surgery Centers
12.3.3. Neurology Centers
12.3.4. Diagnostic Centers
12.3.5. Home Care Settings
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Epilepsy Monitoring Devices Market – Opportunity Analysis Index, By Product, By Technology, By End User, and Country, 2022-2028
12.6. Latin America Epilepsy Monitoring Devices Market Dynamics – Trends
13. Middle East and Africa Epilepsy Monitoring Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Wearable Devices
13.1.2. Conventional Devices
13.1.3. Implantable Devices
13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Vagus Nerve Stimulation (VNS)
13.2.2. Responsive Neurostimulation
13.2.3. Deep Brain Stimulation
13.2.4. Accelerometry
13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Hospitals and Clinics
13.3.2. Ambulatory Surgery Centers
13.3.3. Neurology Centers
13.3.4. Diagnostic Centers
13.3.5. Home Care Settings
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. South Africa
13.4.3. Rest of MEA
13.5. MEA Epilepsy Monitoring Devices Market – Opportunity Analysis Index, By Product, By Technology, By End User, and Country, 2022-2028
13.6. MEA Epilepsy Monitoring Devices Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Key Products, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Koninklijke Philips N.V
14.2.2. Natus Medical, Inc. (US)
14.2.3. Compumedics Limited (Australia)
14.2.4. Empatica, Inc. (US)
14.2.5. Abbott Laboratories, Inc. (US)
14.2.6. LivAssured B.V. (Netherlands)
14.2.7. BioSerenity (France)
14.2.8. The Magstim Co. Ltd. (UK)
14.2.9. Nihon Kohden Corporation (Japan)
14.2.10. Medtronic Plc (Ireland)
14.2.11. Masimo Corporation (US)
14.2.12. Boston Scientific Corporation (US)
14.2.13. Aleva Neurotherapeutics (Switzerland)
14.2.14. Medpage, Ltd. (UK)
14.2.15. Neurosoft (Russia)
15. Research Methodology
16. Key Assumptions and Acronyms

Report

Company Profile

  • Koninklijke Philips N.V
  • Natus Medical, Inc. (US)
  • Compumedics Limited (Australia)
  • Empatica, Inc. (US)
  • Abbott Laboratories, Inc. (US)
  • LivAssured B.V. (Netherlands)
  • BioSerenity (France)
  • The Magstim Co. Ltd. (UK)
  • Nihon Kohden Corporation (Japan)
  • Medtronic Plc (Ireland)
  • Masimo Corporation (US)
  • Boston Scientific Corporation (US)
  • Aleva Neurotherapeutics (Switzerland)
  • Medpage, Ltd. (UK)
  • Neurosoft (Russia)

Description

Epilepsy Monitoring Devices Market size is valued at USD 525 million in 2021 and is poised to grow at a significant CAGR of 4.9% over 2022–2028. Epilepsy is a neurological disorder, it affects the central nervous system in which brain activity becomes abnormal, causing seizures or periods of unusual behaviour, sensations, temporary confusion, uncontrollable jerking movements of arms and legs, and loss of awareness. Anyone can develop epilepsy irrespective of males and females of all races, ethnic backgrounds, and ages. According to WHO, around 50 million people worldwide have epilepsy, and nearly 80% of people with epilepsy live in low- and middle-income countries. It is estimated that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. The increasing prevalence of epilepsy and incidence of head injuries, brain cancer, and infections are driving the epilepsy monitoring devices market share. Around 5 million people are diagnosed with epilepsy each year worldwide. Moreover, the rise in research & development activities with the immense investment and the awareness about epilepsy monitoring devices is expected to increase the epilepsy devices market demand. Various awareness programs organized by organizations and government initiatives will further increase the awareness and growth of the market.  However, the high cost of complex epilepsy monitoring procedures and devices is a significant restrain that limits the market growth. For instance, handling MEG devices is very challenging for healthcare facilities in countries that have implemented this monitoring equipment. Although increasing demand for non-invasive and minimally invasive devices shows the opportunity in the global epilepsy monitoring devices market trends. Invasive monitoring is a very risky, intricate, and painful process that needs direct intervention with the brain’s sensitive tissues. As a result, patients and doctors are more interested in using minimally or non-invasive epilepsy monitoring technologies.

 

Recent Market Developments:

In Feb 2022, Angelini Pharma, an international Italian pharmaceutical company, announced that it would provide patients and healthcare professionals with innovative solutions to improve the care of patients with epilepsy.

In January 2021, Nihon Kohden launched disposable EEG electrodes to help prevent cross-contamination between patients and healthcare workers.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX